Back to companies
PORTFOLIO
Gemma Biotherapeutics
GEMMABio, a new therapeutics company developing AAV based therapies, with a platform of new AAV serotypes, with a clinical pipeline focusing on pediatric monogenic diseases, and with a large preclinical pipeline for other large impact diseases.
Milestones
Founded: 2024 Invested: 2024
Leadership Team
James Wilson
HQ
Pennsylvania, USA
Earlybird Deal Team
OUR PORTFOLIO
SIMILAR COMPANIES
Meet the companies we’ve backed on their way to creating groundbreaking change.
WE INVEST BECAUSE
WE BELIEVE
Got an idea that could change the world? If you're an early-stage founder with big ambitions, we'd love to hear from you.
